Lam Research Corporation $LRCX Position Trimmed by Benjamin Edwards Inc.

Benjamin Edwards Inc. decreased its holdings in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 26.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 95,651 shares of the semiconductor company's stock after selling 35,284 shares during the period. Benjamin Edwards Inc.'s holdings in Lam Research were worth $41,454,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in LRCX. Brighton Jones LLC lifted its holdings in shares of Lam Research by 1,032.4% during the 4th quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company's stock valued at $1,025,000 after buying an additional 12,936 shares during the last quarter. Caxton Associates LLP bought a new position in Lam Research during the first quarter valued at approximately $239,000. Gabelli Funds LLC bought a new stake in Lam Research in the second quarter worth approximately $253,000. NewEdge Advisors LLC increased its stake in shares of Lam Research by 2.7% during the 2nd quarter. NewEdge Advisors LLC now owns 100,528 shares of the semiconductor company's stock worth $9,785,000 after purchasing an additional 2,661 shares during the last quarter. Finally, Osterweis Capital Management Inc. increased its stake in shares of Lam Research by 5,206.7% during the 2nd quarter. Osterweis Capital Management Inc. now owns 796 shares of the semiconductor company's stock worth $77,000 after purchasing an additional 781 shares during the last quarter. 84.61% of the stock is owned by hedge funds and other institutional investors.

Lam Research Stock Down 5.2%

LRCX stock opened at $301.90 on Friday. Lam Research Corporation has a twelve month low of $94.11 and a twelve month high of $438.50. The company has a quick ratio of 1.91, a current ratio of 2.63 and a debt-to-equity ratio of 0.30. The company has a market cap of $377.77 billion, a PE ratio of 52.41, a price-to-earnings-growth ratio of 1.20 and a beta of 1.84. The business's 50-day simple moving average is $330.43 and its 200 day simple moving average is $289.14.

Lam Research (NASDAQ:LRCX - Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 EPS for the quarter, beating the consensus estimate of $1.69 by $0.13. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The firm had revenue of $6.72 billion during the quarter, compared to analysts' expectations of $6.66 billion. During the same quarter in the prior year, the firm posted $1.33 EPS. The company's revenue for the quarter was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. On average, research analysts anticipate that Lam Research Corporation will post 9.33 earnings per share for the current year.

Lam Research Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 14th. Investors of record on Wednesday, September 23rd will be given a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 0.4%. This is an increase from Lam Research's previous quarterly dividend of $0.26. The ex-dividend date of this dividend is Wednesday, September 23rd. Lam Research's dividend payout ratio (DPR) is 18.06%.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on LRCX. Stifel Nicolaus boosted their price target on Lam Research from $325.00 to $425.00 and gave the stock a "buy" rating in a research report on Friday, July 10th. Susquehanna reaffirmed a "positive" rating and set a $475.00 target price (up from $385.00) on shares of Lam Research in a research report on Tuesday, June 30th. Raymond James Financial set a $425.00 price objective on shares of Lam Research in a research note on Wednesday, June 10th. B. Riley Financial dropped their target price on shares of Lam Research from $385.00 to $350.00 and set a "buy" rating on the stock in a report on Thursday, July 30th. Finally, Wall Street Zen cut shares of Lam Research from a "buy" rating to a "hold" rating in a report on Sunday, May 10th. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $357.31.

Insiders Place Their Bets

In other Lam Research news, Director Abhijit Y. Talwalkar sold 18,282 shares of the business's stock in a transaction on Monday, July 13th. The shares were sold at an average price of $335.00, for a total value of $6,124,470.00. Following the sale, the director owned 87,142 shares of the company's stock, valued at $29,192,570. The trade was a 17.34% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the stock in a transaction on Thursday, June 11th. The shares were sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the completion of the transaction, the director owned 199,205 shares of the company's stock, valued at approximately $69,881,114. This represents a 21.48% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 80,441 shares of company stock worth $27,614,296 over the last 90 days. Corporate insiders own 0.31% of the company's stock.

Key Headlines Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Lam Research broke ground on a 120,000-square-foot Oregon semiconductor laboratory as part of a planned investment of more than $3 billion in its global lab network over five years. The project is intended to accelerate process innovations for advanced AI chips and improve collaboration with customers, supporting the company’s long-term growth prospects. Lam Research breaks ground on AI semiconductor lab in Oregon
• Positive Sentiment: The board approved a 27% increase in the quarterly dividend, from $0.26 to $0.33 per share. The payout is scheduled for October 14, 2026, for shareholders of record on September 23, providing a modest shareholder-return signal. Lam Research Corporation Announces a 27% Increase in Quarterly Dividend
• Neutral Sentiment: Lam’s latest earnings exceeded consensus expectations, with quarterly earnings per share of $1.82 versus the $1.69 estimate and revenue of $6.72 billion. Revenue increased 30% year over year, while management issued fiscal first-quarter 2027 EPS guidance of $2.00 to $2.30. Analysts’ median price target remains substantially above recent trading levels, although Mizuho recently lowered its target to $365.
• Neutral Sentiment: Two long-serving directors, Michael R. Cannon and Sohail U. Ahmed, plan to retire from the board on November 2, 2026. The transition could refresh governance but introduces some near-term uncertainty regarding board composition. Lam Research Announces Retirement of Michael R. Cannon and Sohail U. Ahmed from Board of Directors
• Negative Sentiment: Investors appear increasingly concerned about tariffs, export restrictions and other U.S.-China trade measures. China was Lam’s largest geographic market in fiscal 2026, making the company particularly sensitive to policy changes that could reduce demand, hurt margins or disrupt its supply chain. These macro concerns have overshadowed the dividend increase and Oregon expansion. Lam Research Slides as China Trade Risk Appears to Outweigh Dividend Hike
• Negative Sentiment: Reported insider activity shows selling rather than buying by executives and directors over the past six months, which may reinforce caution among investors, though such transactions can reflect personal financial planning rather than a view on company fundamentals.

About Lam Research

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source